Spray characterization specialist Proveris Scientific has announced that it is now offering contract testing services for OINDP regulatory submissions, release testing and stability studies, as well as for development projects.
The company received ISO 9001:2015 certification in 2018, and the laboratory now also meets cGMP requirements for both the FDA and the EMA. According to Proveris, cGMP compliance “offers customers assurance that test services performed on their drug products meet the highest of quality standards for regulatory submission.”
In the past few years, the company has expanded both its services and its workforce. Proveris, which is celebrating its 25th anniversary in 2020, also sells OINDP testing equipment such as the SprayView spray characterization systems, Vereo automated actuators, and the Kinaero fire down systems in addition to offering OINDP test services.
Proveris Founder and CEO Dino J. Farina said, “We are excited to elevate our laboratory from its humble beginnings over 15 years ago as the genesis for countless development projects with our customers around the world to the level required for cGMP compliance. This achievement confirms our commitment and continued investment in the OINDP arena and to accelerating the development efforts we are involved in with our customers around the world.”
President Chip Leveille added, “As a testament to our high standards of excellence, we are proud to add cGMP compliance in our laboratory services offering as another milestone in our history. I am very proud of our team here, who make dedication to quality products, services, and the success of our customers a daily focus. It is a great feat for all of us to see our quality culture culminate in this achievement.”
Read the Proveris Scientific press release.
